Neda Dadgar

13PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 13, 2025
Blood-Based Surveillance Biomarkers for Gastroesophageal Cancers.

Neda Dadgar, Muhammad Anees, Christopher Sherry

|Sep 26, 2025
The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal Carcinomatosis.

Christopher Sherry, Neda Dadgar, Zuqiang Liu

|Jul 30, 2025
Fusobacterium nucleatum Is Associated with Tumor Characteristics, Immune Microenvironment, and Survival in Appendiceal Cancer.

Christopher Sherry, Neda Dadgar, Hyun Park

|Feb 13, 2025
Intra-Tumoral CD8+:CD3+ Lymphocyte Density Ratio in Appendix Cancer Is a Tumor Volume- and Grade-Independent Predictor of Survival.

Chelsea Knotts, Hyun Park, Christopher Sherry

|Sep 28, 2024
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy.

Neda Dadgar, Arun K Arunachalam, Hanna Hong

|Oct 28, 2023
Regional Immunotherapy for Peritoneal Carcinomatosis in Gastroesophageal Cancer: Emerging Strategies to Re-Condition a Maladaptive Tumor Environment.

Catherine R Lewis, Neda Dadgar, Samuel A Yellin

Pageof 3

Frequent Collaborators

4 joint publications

Ali H Zaidi

4 joint publications

David L Bartlett

4 joint publications

Patrick L Wagner

3 joint publications

Kunhong Xiao